1. Home
  2. XPON vs PMCB Comparison

XPON vs PMCB Comparison

Compare XPON & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Expion360 Inc.

XPON

Expion360 Inc.

N/A

Current Price

$2.50

Market Cap

4.1M

Sector

Technology

ML Signal

N/A

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

N/A

Current Price

$0.37

Market Cap

4.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
XPON
PMCB
Founded
2016
1996
Country
United States
United States
Employees
N/A
2
Industry
Electronic Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1M
4.0M
IPO Year
2022
2001

Fundamental Metrics

Financial Performance
Metric
XPON
PMCB
Price
$2.50
$0.37
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.8K
★ 99.3K
Earning Date
11-16-2026
12-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 94.63
N/A
EPS
N/A
★ N/A
Revenue
★ $9,651,870.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 71.59
N/A
52 Week Low
$0.26
$0.30
52 Week High
$11.79
$1.51

Technical Indicators

Market Signals
Indicator
XPON
PMCB
Relative Strength Index (RSI) 29.06 50.38
Support Level $0.51 $0.32
Resistance Level $3.82 $0.40
Average True Range (ATR) 0.34 0.04
MACD -0.10 0.01
Stochastic Oscillator 14.21 58.20

Price Performance

Historical Comparison
XPON
PMCB

About XPON Expion360 Inc.

Expion Energy Inc is engaged in premium lithium iron phosphate (LiFePO4) batteries and accessories for recreational vehicles, marine applications, Light EV and industrial applications. The company's lithium-ion batteries feature half the weight of standard lead-acid batteries while delivering three times the power and ten times the number of charging cycles. The company's batteries also feature construction and reliability compared to other lithium-ion batteries on the market due to their superior design and quality materials.

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.

Share on Social Networks: